Targeting actin inhibits repair of doxorubicin-induced DNA damage: a novel therapeutic approach for combination therapy.

Pfitzer L, Moser C, Gegenfurtner F, Arner A, Foerster F, Atzberger C, Zisis T, Kubisch-Dohmen R, Busse J, Smith R, Timinszky G, Kalinina OV, Muller R, Wagner E, Vollmar AM, Zahler S
Cell Death Dis. 2019 Apr 3;10(4):302. doi: 10.1038/s41419-019-1546-9. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.